Intraoperative urological complications in transurethral surgical interventions on the prostate for benign hyperplasia

医学 经尿道前列腺电切术 前列腺 尿道 增生 穿孔 外科 泌尿科 开放性前列腺切除术 膀胱出口梗阻 国际前列腺症状评分 下尿路症状 前列腺切除术 内科学 材料科学 冶金 冲孔 癌症
作者
А Г Мартов,С. И. Корниенко,B L Gushchin,Д В Ергаков,O A Sazonov
出处
期刊:Urologii︠a︡ (Russia) 卷期号: (4): 3-8 被引量:13
标识
摘要

Wide clinical introduction of endoscopic methods in management of lower urinary tract (LUT) diseases is explained both by their high efficacy and relative safety. In spite of perfection of endourological tools, no large-scale clinical trials have been performed of late analyzing the rate of complications of endoscopic treatment of benign prostatic hyperplasia (BPH). A total of 5401 transurethral endoscopic operations were made in BPH patients. The spectrum of endoscopic operations made in the Research Institute of Urology (1991-2003) and Krasnodar Regional Hospital N 1 (1998-2003) covered the following operations: transurethral prostatic resection (5003-92.6%), transurethral prostatic incision (112-2.1%), transurethral rolling electrovaporisation of the prostate (119-2.2%), transurethral vaporizing resection of the prostate (107-1.98%), transurethral rotoresection of the prostate (60-1.1%). Overall number of intraoperative complications was 191 or 3.5%. Most frequent complications were closed and open perforation of the prostatic capsule (1.6 and 0.4%, respectively), a mechanical trauma of the prostate and urethra (0.3 and 0.15%, respectively), development of the syndrome of water intoxication (0.13%), intraoperative blood loss compensated by hemotransfusion (0.5%). Rare complications comprised injury of the ureteral ostia (0.09%), rupture of the urinary bladder (0.02%). Thus, transurethral endoscopic surgery is characterized by high safety, a trend to lowering of the number of intraoperative complications in transurethral endoscopic operations. Adherence to specification and TUR techniques leads to minimization of serious complications number.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爆米花应助昏睡的人杰采纳,获得10
2秒前
刘漂亮完成签到,获得积分10
2秒前
生动的访琴完成签到,获得积分10
2秒前
4秒前
WERTUYU完成签到 ,获得积分10
4秒前
5秒前
Fearless完成签到,获得积分20
5秒前
guo发布了新的文献求助10
5秒前
duzhi完成签到 ,获得积分10
5秒前
科研通AI6.2应助大方的蓝采纳,获得10
6秒前
6秒前
维尼熊完成签到 ,获得积分10
7秒前
Fearless发布了新的文献求助10
9秒前
在水一方应助mmm采纳,获得10
10秒前
11秒前
117完成签到 ,获得积分10
11秒前
慬Q发布了新的文献求助10
11秒前
小马甲应助jcx采纳,获得10
13秒前
千里江山一只蝇完成签到,获得积分10
14秒前
脑洞疼应助笑寒采纳,获得10
14秒前
blue完成签到 ,获得积分10
14秒前
15秒前
16秒前
17秒前
18秒前
希望天下0贩的0应助mi采纳,获得10
19秒前
粗暴的朋友完成签到,获得积分10
19秒前
任性访风完成签到,获得积分10
19秒前
21秒前
22秒前
22秒前
24秒前
24秒前
Twilight发布了新的文献求助10
25秒前
26秒前
ad完成签到,获得积分10
26秒前
孟斯扬完成签到,获得积分10
28秒前
jcx发布了新的文献求助10
28秒前
Yun发布了新的文献求助10
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 1100
3O - Innate resistance in EGFR mutant non-small cell lung cancer (NSCLC) patients by coactivation of receptor tyrosine kinases (RTKs) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Proceedings of the Fourth International Congress of Nematology, 8-13 June 2002, Tenerife, Spain 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5938058
求助须知:如何正确求助?哪些是违规求助? 7040073
关于积分的说明 15872602
捐赠科研通 5067692
什么是DOI,文献DOI怎么找? 2725593
邀请新用户注册赠送积分活动 1684112
关于科研通互助平台的介绍 1612270